Intellia Therapeutics
NTLA
$22.92
Share price
-5.56%
Change (1 day)
-41.61%
Change (1 year)
Intellia Therapeutics (NTLA) Fails to deliver data
Key failure to deliver metrics for Intellia Therapeutics:
- Last SEC data release: 2024-03-28
- Last 15 days FTD volume: N/A
- Last 3 months FTD volume: $0.62 M
- Last year FTD volume: $4.15 M
Failures to deliver for Intellia Therapeutics (NTLA) - 3 months history
Number of shares, 3 months chartBiweekly Failures to deliver volume for Intellia Therapeutics (NTLA) - since 2016
Volume in USD (price x number of shares), data since 2016Intellia Therapeutics (NTLA) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2024 | $0.61 M | -87.2% |
| 2023 | $4.81 M | -74.6% |
| 2022 | $18.94 M | -78.06% |
| 2021 | $86.32 M | 59.26% |
| 2020 | $54.2 M | 91.14% |
| 2019 | $28.35 M | -26.57% |
| 2018 | $38.61 M | 258.03% |
| 2017 | $10.78 M | 16.86% |
| 2016 | $9.23 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3months) | FTD volume (1 year) | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $2.19 M | $6.79 M | 🇺🇸 USA |